Laboratory diagnosis of mycoplasma infections.

Isr J Med Sci

Published: October 1984

The relative efficiency of different media for the isolation of M. pneumoniae is discussed, with emphasis on the utility of SP-4 medium as a primary medium for isolation. Media available for isolation and identification of ureaplasmas are also described. Rapid methods of identification of isolated mycoplasmas are surveyed. The use and value of serologic procedures in the clinical laboratory are evaluated with particular reference to the complement fixation procedure and its value as compared to other methods. The possibilities for the development of direct antigen detection procedures for clinical use are discussed with particular reference to ELISA and other antigen capture methods. The problems that arise in susceptibility testing of isolates are raised, and a usable procedure is proposed both for minimal inhibitory concentration and minimal bacteriocidal concentration determination. A general procedure for the laboratory diagnosis of mycoplasmal infection that is adaptable to various laboratory circumstances and needs is proposed.

Download full-text PDF

Source

Publication Analysis

Top Keywords

laboratory diagnosis
8
media isolation
8
procedures clinical
8
laboratory
4
diagnosis mycoplasma
4
mycoplasma infections
4
infections relative
4
relative efficiency
4
efficiency media
4
isolation pneumoniae
4

Similar Publications

SARS-CoV-2 Infection of the Central Nervous System: A Case Report.

Viruses

December 2024

Department of Medical Oncology, Medical University of Sofia, University Hospital "Tsaritsa Yoanna", 1527 Sofia, Bulgaria.

Central nervous system (CNS) infections caused by SARS-CoV-2 are uncommon. This case report describes the clinical progression of a 92-year-old female who developed a persistent neuroinfection associated with SARS-CoV-2. The patient initially presented with progressive fatigue, catarrhal symptoms, and a fever (38.

View Article and Find Full Text PDF

Development of a Synthetic VP1 Protein Peptide-Based ELISA to Detect Antibodies Against Porcine Bocavirus Group 3.

Viruses

December 2024

Xinjiang Key Laboratory of New Drug Study and Creation for Herbivorous Animals (XJ-KLNDSCHA), College of Veterinary Medicine, Xinjiang Agricultural University, Urumqi 830052, China.

Porcine bocavirus (PBoV), classified within the genus Bocaparvovirus, has been reported worldwide. PBoV has been divided into group 1, group 2, and group 3. PBoV group 3 (G3) viruses are the most prevalent in China.

View Article and Find Full Text PDF

Photodynamic inactivation (PDI) has been revealed as a valuable approach against viral infections because of the fast therapeutic effect and low possibility of resistance development. The photodynamic inhibition of the infectivity of human herpes simplex virus type 1 (HSV-1) strain Victoria at different stages of its reproduction was studied. PDI activity was determined on extracellular virions, on the stage of their adsorption to the Madin-Darby bovine kidney (MDBK) cell line and inhibition of the viral replication stage by application of two tetra-methylpyridiloxy substituted gallium and zinc phthalocyanines (ZnPcMe and GaPcMe) upon 660 nm light exposure with a light-emitting diode (LED 660 nm).

View Article and Find Full Text PDF

Setting up a global SARS-CoV-2 surveillance system requires an understanding of how virus isolation and propagation practices, use of animal or human sera, and different neutralisation assay platforms influence assessment of SARS-CoV-2 antigenicity. In this study, with the contribution of 15 independent laboratories across all WHO regions, we carried out a controlled analysis of neutralisation assay platforms using the first WHO International Standard for antibodies to SARS-CoV-2 variants of concern (source: NIBSC). Live virus isolates (source: WHO BioHub or individual labs) or spike plasmids (individual labs) for pseudovirus production were used to perform neutralisation assays using the same serum panels.

View Article and Find Full Text PDF

Ebola virus (EBOV) causes severe disease in humans, with mortality as high as 90%. The small-molecule antiviral drug remdesivir (RDV) has demonstrated a survival benefit in EBOV-exposed rhesus macaques. Here, we characterize the efficacy of multiple intravenous RDV dosing regimens on survival of rhesus macaques 42 days after intramuscular EBOV exposure.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!